UiPath (NYSE:PATH) Shares Up 0.7%

UiPath Inc. (NYSE:PATH)’s stock price was up 0.7% during trading on Thursday . The company traded as high as $19.29 and last traded at $19.25. Approximately 1,302,453 shares changed hands during trading, a decline of 85% from the average daily volume of 8,911,960 shares. The stock had previously closed at $19.12.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Morgan Stanley boosted their price objective on shares of UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research report on Thursday, March 14th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $29.00 price objective on shares of UiPath in a research report on Monday, April 1st. Scotiabank lifted their target price on UiPath from $29.00 to $30.00 and gave the company a “sector perform” rating in a research report on Thursday, March 14th. TD Cowen lifted their price objective on shares of UiPath from $25.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, March 14th. Finally, Barclays raised their target price on shares of UiPath from $23.00 to $25.00 and gave the company an “equal weight” rating in a research report on Friday, March 15th. Nine equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $27.41.

UiPath Trading Down 1.6 %

The company has a market cap of $10.66 billion, a price-to-earnings ratio of -110.23 and a beta of 0.96. The business’s 50 day moving average price is $22.82 and its 200-day moving average price is $21.45.

UiPath (NYSE:PATH) last issued its quarterly earnings data on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. The company had revenue of $405.25 million during the quarter, compared to analysts’ expectations of $383.32 million. UiPath had a negative return on equity of 3.29% and a negative net margin of 6.87%. Equities research analysts forecast that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 16,000 shares of the business’s stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $22.84, for a total value of $365,440.00. Following the completion of the sale, the chief financial officer now owns 87,505 shares of the company’s stock, valued at $1,998,614.20. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 72,000 shares of company stock worth $1,591,360 in the last 90 days. Company insiders own 31.03% of the company’s stock.

Institutional Investors Weigh In On UiPath

A number of large investors have recently added to or reduced their stakes in PATH. Mark Sheptoff Financial Planning LLC acquired a new stake in shares of UiPath during the 4th quarter worth $25,000. HighMark Wealth Management LLC acquired a new position in shares of UiPath in the 4th quarter valued at approximately $27,000. Cypress Capital Management LLC WY bought a new stake in shares of UiPath during the 4th quarter worth approximately $29,000. GAMMA Investing LLC acquired a new stake in shares of UiPath during the 4th quarter worth approximately $36,000. Finally, Mango Five Family Inc. bought a new position in UiPath in the fourth quarter valued at approximately $40,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.